SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-010125
Filing Date
2012-11-06
Accepted
2012-11-06 16:32:20
Documents
16
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2211595z10-q.htm 10-Q 808753
2 EX-10.1 a2211595zex-10_1.htm EX-10.1 71172
3 EX-10.2 a2211595zex-10_2.htm EX-10.2 59885
4 EX-10.3 a2211595zex-10_3.htm EX-10.3 62188
5 EX-10.4 a2211595zex-10_4.htm EX-10.4 54461
6 EX-31.1 a2211595zex-31_1.htm EX-31.1 7668
7 EX-31.2 a2211595zex-31_2.htm EX-31.2 7682
8 EX-32.1 a2211595zex-32_1.htm EX-32.1 4356
15 G198882KII001.JPG g198882kii001.jpg GRAPHIC 2562
16 G198882KMI001.JPG g198882kmi001.jpg GRAPHIC 2562
  Complete submission text file 0001047469-12-010125.txt   9395004

Data Files

Seq Description Document Type Size
9 EX-101.INS vrtx-20120930.xml EX-101.INS 931038
10 EX-101.SCH vrtx-20120930.xsd EX-101.SCH 141027
11 EX-101.CAL vrtx-20120930_cal.xml EX-101.CAL 87075
12 EX-101.LAB vrtx-20120930_lab.xml EX-101.LAB 2093042
13 EX-101.PRE vrtx-20120930_pre.xml EX-101.PRE 859223
14 EX-101.DEF vrtx-20120930_def.xml EX-101.DEF 518723
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 121183635
SIC: 2834 Pharmaceutical Preparations